
Colleen Carvalho, chief mission officer at Bay Area Cancer Connections, explains the emotional and practical needs that often go unaddressed after a diagnosis.
Michael Wong, melanoma oncologist and CURE advisory board member, explains how recent studies are targeting the PD-1 pathway and describes why there is so much excitement surrounding this new class of immunotherapy.






